This inventor holds 3 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd.. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2025
Title: Innovations of Inventor Tong Yang
Introduction
Tong Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative antibodies for cancer treatment. With a total of 3 patents to his name, his work is paving the way for advancements in targeted therapies.
Latest Patents
One of Tong Yang's latest patents is titled "Anti-B7-H3 antibody, preparation method therefor, conjugate and application thereof." This patent describes a fully human anti-B7-H3 antibody that can specifically bind to the B7-H3 antigen on tumor cells. The antibody is designed to rapidly internalize into cells after binding, making it a promising candidate for antibody-drug conjugate (ADC) drug development aimed at enhancing anti-tumor activity and efficacy.
Another notable patent is "Antibody-drug conjugate, and intermediate thereof, preparation method therefor, and application thereof." This invention outlines an antibody-drug conjugate that exhibits good targetability and an effective inhibitory effect on HER3-positive tumor cells. The compound demonstrates high safety and druggability, making it a valuable asset in cancer treatment.
Career Highlights
Tong Yang has worked with reputable companies in the biopharmaceutical sector, including Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co., Ltd. and Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Throughout his career, Tong Yang has collaborated with notable professionals in the field, including Fang Wu and Yijun Shen. These collaborations have further enriched his research and development efforts.
Conclusion
Tong Yang's innovative work in the field of biopharmaceuticals, particularly in the development of targeted antibodies, showcases his commitment to advancing cancer treatment. His contributions are significant and continue to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile